LabCorp

$205.26
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$2.10 (+1.03%) Today
$0.00 (0.00%) As of 8:00 PM EDT after-hours

Why Robinhood?

You can buy or sell LabCorp and other stocks, options, and ETFs commission-free!

About LH

Laboratory Corporation of America Holdings, also called LabCorp, is a clinical laboratory company. The firm engages in the provision of clinical laboratory and end-to-end drug development services. Read More It operates through the following segments: LabCorp Diagnostics and Covance Drug Development. The LabCorp Diagnostics segment includes core testing as well as genomic and esoteric testing. The Covance Drug Development segment provides drug development solutions to companies in the pharmaceutical and biotechnology industries. The company was founded in 1971 and is headquartered in Burlington, NC. The listed name for LH is Laboratory Corporation of America Holdings.

Employees
65,000
Headquarters
Burlington, North Carolina
Founded
1971
Market Cap
19.99B
Price-Earnings Ratio
55.92
Dividend Yield
Average Volume
589.43K
High Today
$205.66
Low Today
$201.86
Open Price
$204.38
Volume
609.76K
52 Week High
$207.03
52 Week Low
$98.02

Collections

LH News

ReutersOct 19

LabCorp launches test to measure COVID-19 antibodies in clinical trials

Oct 19 (Reuters) - LabCorp said on Monday it has launched a test that can measure antibodies a person has produced against the novel coronavirus, to determine t

LH Earnings

$0.00
$0.98
$1.95
$2.93
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Q2 2020
Q3 2020
Estimated
per share
Actual
Available Oct 27, Pre-Market

You May Also Like